Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Saeka
Contact Saeka, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Successful Retreatment of Chronic Hepatitis C Virus Genotype 1A Infection With Glecaprevir/Pibrentasvir in a Pediatric Patient With Developmental Disorder
Keywords: Chronic hepatitis C virus infection genotype 1A glecaprevir pibrentasvir direct-acting antiviral agents development disorder Introduction The pangenotypic, ribavirin-free combination therapy glecaprevir/pibrentasvir (GLE/PIB) has enabled sustained virological response (SVR) in nearly 100% of cases (1-3). However, identifying effective treatments for patients with failed GLE/PIB therapy has become an urgent priority.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Saeka
Contact Saeka, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack